DNA profiling used on cannabis plants

July 09, 2003

FORENSIC scientists in the US are applying DNA fingerprinting methods to the cannabis plant. They say the technique, which is being used to create a database of DNA profiles of different marijuana plants, will help them to trace the source of any sample.

"It links everybody together: the user, the distributor, the grower," says the database's creator, Heather Miller Coyle of the Connecticut State Forensic Science Laboratory in Meriden. "That's the real intent of it, to show it's not just one guy with a little bag of marijuana, but it's a group of people."

A method for spotting the tiniest traces of marijuana, based on detecting DNA unique to cannabis chloroplasts, has already been developed in the UK (New Scientist, 7 August 1999, p 21). But the profiling method, based on the same principles as DNA fingerprinting of people, can distinguish between closely related cannabis plants (Croatian Medical Journal, vol 44, p 315).

In a case awaiting trial in Connecticut, prosecutors plan to use cannabis DNA profiles to show that two apparently separate cannabis growing operations were actually linked. The two operations, in different parts of the state appeared separate until analysis of the plants revealed that some had identical DNA fingerprints, showing that the growers were sharing material. "From the investigative point of view that was phenomenal," says Timothy Palmbach, director of scientific services at the laboratory.

The big difference between human and plant DNA fingerprinting is that in people, each fingerprint is almost certainly unique to one person. So if a crime scene sample matches a person's profile, there is little doubt that it came from that individual.

In plants, by contrast, identical clones are easily created by taking cuttings, a method growers often use to perpetuate potent strains of dope. So showing two samples have matching DNA profiles does not by itself prove they come from the same grower, let alone the same plant.

But Palmbach says that growers tend not to give away cuttings of their best plants, so linking samples in this way is an important lead for investigators and will still be useful in tracing samples. "What growers have done to get more potent plants has played right into our hands," says Palmbach. And if several matching profiles are found in separate samples, the chances are high that they are somehow linked.

Coyle is establishing a database of DNA profiles from hundreds of marijuana samples seized in Connecticut. "We want to track how many varieties are out there, what the trends in distribution are, the probability that a plant can be related to another," says Palmbach. The database is being extended to include samples from all over the US and the rest of the world. "We invite anyone to send us samples," says Coyle.

Exactly how law enforcement agencies will apply the method remains to be seen. If a link can be established between a user and a grower or dealer, casual users might find themselves in deeper trouble than they bargained for. "If you're buying marijuana from somebody with terrorist ties, it could be traced back to that person," warns Gary Shutler of the Washington State Patrol's crime laboratory division.

On the other hand, he says, where medical uses of marijuana are legal, the technology could help characterise strains with the desired medicinal properties. Several US states have voted to legalise the medical use of cannabis, though these efforts are being fought by federal authorities.

The technology will not help police investigating the production or sale of highly processed or synthetic drugs such as cocaine and ecstasy. Nor does the team think it would work with hashish, which is made from resin exuded by cannabis plants, as not enough cellular material can be recovered. If the cannabis profiling technique does prove to be an effective tool in investigations and in the courtroom, dealers may switch to selling hashish.
-end-
Sylvia Pagan Westphal

UK CONTACT - Claire Bowles, New Scientist Press Office, London:
Tel: 44-207-331-2751 or email claire.bowles@rbi.co.uk
US CONTACT - Michelle Soucy, New Scientist Boston Office:
Tel: 617-558-4939 or email michelle.soucy@newscientist.com

New Scientist issue: 12th July 2003

PLEASE MENTION NEW SCIENTIST AS THE SOURCE OF THIS STORY AND, IF PUBLISHING ONLINE, PLEASE CARRY A HYPERLINK TO: http://www.newscientist.com

"These articles are posted on this site to give advance access to other authorised media who may wish to quote extracts as part of fair dealing with this copyrighted material. Full attribution is required, and if publishing online a link to www.newscientist.com is also required. Advance permission is required before any and every reproduction of each article in full - please contact celia.thomas@rbi.co.uk. Please note that all material is copyright of Reed Business Information Limited and we reserve the right to take such action as we consider appropriate to protect such copyright."

New Scientist

Related Cannabis Articles from Brightsurf:

Cannabis to treat gynecological conditions
A significant number of women would consider using cannabis to treat gynecological conditions, primarily gynecological pain.

Cannabis data lacking, but machine learning could help
Everyone's heard of THC and CBD. But many other active compounds in cannabis interact to influence its effects.

Cannabis use for menopause symptom management
CLEVELAND, Ohio (September 28, 2020)--As legislation relaxes regarding cannabis, it is being used to manage numerous chronic health conditions and mood symptoms.

Prescribed CBD could help people quit cannabis
A benchmark clinical trial published today shows that cannabidiol (CBD) could be a safe and effective treatment for problematic cannabis use.

Pregnant women with depression are more than 3 times more likely to use cannabis
Cannabis use is much more common among pregnant women with depression and pregnant women with depression are more than 3 times more likely to use cannabis than those without depression.

Cannabis compound acts as an antibiotic 
Public health agencies worldwide have identified antibiotic resistance of disease-causing bacteria as one of humanity's most critical challenges.

Cannabis use during pregnancy
The large health care system Kaiser Permanente Northern California provides universal screening for prenatal cannabis use in women during pregnancy by self-report and urine toxicology testing.

Questions and answers about cannabis use during pregnancy
A new study shows that women have many medical questions about the use of cannabis both before and during pregnancy, and during the postpartum period while breastfeeding.

Managing cannabis use in breastfeeding women
As more states legalize medicinal and recreational cannabis use and increasingly decriminalize cannabis, the risk to the growth and development of breastfeeding infants whose mothers use cannabis becomes a growing public health concern.

Cannabis edibles present novel health risks
With the recent legalization of cannabis edibles in Canada, physicians and the public must be aware of the novel risks of cannabis edibles, argue authors in a commentary in CMAJ (Canadian Medical Association Journal).

Read More: Cannabis News and Cannabis Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.